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Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising cancer 
therapeutic agent due to its selective killing on cancer cells while sparing the normal cells. 
Nevertheless, breast adenocarcinoma cells can develop TRAIL resistance. Therefore, this 
project investigated the anti-cancer effects of the combination of epigenetic drugs zebularine 
and trichostatin A (ZT) with TRAIL (TZT) on the human breast adenocarcinoma cells. This 
treatment regimen was compared with the natural anti-cancer compound curcumin (Cur) and 
standard chemotherapeutic drug doxorubicin (Dox). As compared to TRAIL treatment, TZT 
treatment hampered the cell viability of human breast adenocarcinoma cells MDA-MB-231 
significantly but not MCF-7 and immortalized non-cancerous human breast epithelial cells 
MCF10A. Unlike TZT, Cur and Dox treatments reduced cell viability in both human breast 
adenocarcinoma and epithelial cells significantly. Nevertheless, there were no changes in cell 
cycle in both TRAIL and TZT treatments in breast adenocarcinoma and normal epithelial cells. 
Intriguingly, Cur and Dox treatment generally induced G2/M arrest in MDA-MB-231, MCF-7 
and MCF10A but Cur induced S phase arrest in MCF10A. The features of apoptosis such as 
morphological changes, apoptotic activity and the expression of cleaved poly (ADP) ribose 
polymerase (PARP) protein were more prominent in TRAIL and TZT-treated MDA-MB-231 as 
compared to MCF10A at 24 h post-treatment. Compared to TZT treatment, Cur and Dox 
treatments exhibited lesser apoptotic features in MDA-MB-231. Collectively, the sensitization 
using Zeb and TSA to augment TRAIL-induced apoptosis might be an alternative therapy 
towards human breast adenocarcinoma cells, without harming the normal human breast 
epithelial cells. 
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